Engene Holdings Common Etf Price Prediction
| ENGN Etf | USD 8.52 0.37 4.16% |
Oversold Vs Overbought
65
Oversold | Overbought |
EPS Estimate Current Year (1.46) | EPS Estimate Next Year (1.69) | Wall Street Target Price 30.57 | EPS Estimate Current Quarter (0.37) |
Using EnGene Holdings hype-based prediction, you can estimate the value of enGene Holdings Common from the perspective of EnGene Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in EnGene Holdings to buy its etf at a price that has no basis in reality. In that case, they are not buying EnGene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
EnGene Holdings after-hype prediction price | USD 8.91 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
EnGene |
EnGene Holdings After-Hype Price Prediction Density Analysis
As far as predicting the price of EnGene Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in EnGene Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of EnGene Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
EnGene Holdings Estimiated After-Hype Price Volatility
In the context of predicting EnGene Holdings' etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on EnGene Holdings' historical news coverage. EnGene Holdings' after-hype downside and upside margins for the prediction period are 3.38 and 14.44, respectively. We have considered EnGene Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
EnGene Holdings is slightly risky at this time. Analysis and calculation of next after-hype price of enGene Holdings Common is based on 3 months time horizon.
EnGene Holdings Etf Price Prediction Analysis
Have you ever been surprised when a price of a ETF such as EnGene Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EnGene Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with EnGene Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 5.53 | 0.02 | 0.01 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
8.52 | 8.91 | 0.22 |
|
EnGene Holdings Hype Timeline
enGene Holdings Common is currently traded for 8.52. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.01. EnGene is forecasted to increase in value after the next headline, with the price projected to jump to 8.91 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.22%, whereas the daily expected return is currently at 0.37%. The volatility of related hype on EnGene Holdings is about 21639.13%, with the expected price after the next announcement by competition of 8.51. Net Loss for the year was (99.92 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out EnGene Holdings Basic Forecasting Models to cross-verify your projections.EnGene Holdings Related Hype Analysis
Having access to credible news sources related to EnGene Holdings' direct competition is more important than ever and may enhance your ability to predict EnGene Holdings' future price movements. Getting to know how EnGene Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how EnGene Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DWTX | Dogwood Therapeutics, | 0.74 | 5 per month | 8.37 | 0.01 | 14.60 | (10.62) | 50.54 | |
| ENLV | Enlivex Therapeutics | (0.04) | 3 per month | 3.20 | 0.01 | 6.90 | (4.65) | 28.12 | |
| ENSC | Ensysce Biosciences | (0.22) | 8 per month | 8.65 | 0.09 | 27.27 | (17.24) | 183.07 | |
| ENTO | Entero Therapeutics, | (0.02) | 9 per month | 12.46 | 0.09 | 24.44 | (13.33) | 90.66 | |
| ENTX | Entera Bio | 0.00 | 6 per month | 3.12 | 0.04 | 5.47 | (5.47) | 29.16 | |
| ENTA | Enanta Pharmaceuticals | (0.20) | 4 per month | 0.00 | (0.14) | 4.47 | (6.14) | 17.30 | |
| EPIX | ESSA Pharma | (0.50) | 7 per month | 0.00 | (0.10) | 9.30 | (7.04) | 25.73 | |
| EPRX | Eupraxia Pharmaceuticals Common | 0.00 | 0 per month | 4.00 | 0.03 | 6.35 | (7.63) | 16.87 | |
| ERAS | Erasca Inc | 0.01 | 8 per month | 0.00 | (0.04) | 7.34 | (6.21) | 17.95 |
EnGene Holdings Additional Predictive Modules
Most predictive techniques to examine EnGene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for EnGene using various technical indicators. When you analyze EnGene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About EnGene Holdings Predictive Indicators
The successful prediction of EnGene Holdings stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as enGene Holdings Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of EnGene Holdings based on analysis of EnGene Holdings hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to EnGene Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to EnGene Holdings's related companies.
Story Coverage note for EnGene Holdings
The number of cover stories for EnGene Holdings depends on current market conditions and EnGene Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that EnGene Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about EnGene Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
EnGene Holdings Short Properties
EnGene Holdings' future price predictability will typically decrease when EnGene Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of enGene Holdings Common often depends not only on the future outlook of the potential EnGene Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EnGene Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.2 M | |
| Cash And Short Term Investments | 81.5 M |
Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.